ASX:EXL

Elixinol Wellness Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive EXL News and Ratings via Email

Sign-up to receive the latest news and ratings for Elixinol Wellness and its competitors with MarketBeat's FREE daily newsletter.

About Elixinol Wellness

Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Elixinol Wellness and CannaCare Health terminate acquisition as changing German market dynamics threaten returns
June 29, 2021 | proactiveinvestors.com.au

Elixinol Introduces the First CBD Capsules Powered by Ginfort™
April 27, 2021 | finance.yahoo.com

Elixinol Global sees steady improvements in first quarter revenue as UK COVID restrictions ease and US stimulus packages take effect
April 26, 2021 | proactiveinvestors.com

Elixinol (ASX:EXL) share price heats up on cannabis business update
April 26, 2021 | fool.com.au

Elixinol Global's products pass key administrative check by Food Standards Agency and can remain for sale in UK market
March 24, 2021 | proactiveinvestors.com

Elixinol Global's (ASX:EXL) Shareholders Are Down 83% On Their Shares
February 17, 2021 | finance.yahoo.com

Worldwide CBD Oil Industry to 2025 - Key Drivers, Challenges and Trends
February 12, 2021 | marketwatch.com

CBD Market Size to Reach USD 2,207.16 Million by 2026 at Significant CAGR of 125.58%, Predicts Market Research Future (MRFR)
February 8, 2021 | marketwatch.com

Elixinol Global substantial holder Regal Funds Management increases stake
February 8, 2021 | proactiveinvestors.com.au

Elixinol Global Ltd.
February 2, 2021 | barrons.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolASX:EXL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.elixinolglobal.com
Phone61 2 4044 4585
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$15.01 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.11 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Elixinol Wellness.

0.0 Community Rank

Outperform Votes
Elixinol Wellness has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Elixinol Wellness has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Elixinol Wellness and other stocks. Vote “Outperform” if you believe EXL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EXL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Elixinol Wellness does not currently pay a dividend.
Dividend Growth
Elixinol Wellness does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elixinol Wellness insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Elixinol Wellness (ASX:EXL) Frequently Asked Questions

What stocks does MarketBeat like better than Elixinol Wellness?

Wall Street analysts have given Elixinol Wellness a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Elixinol Wellness wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Elixinol Wellness' next earnings date?

Elixinol Wellness is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for Elixinol Wellness.

Who are Elixinol Wellness' key executives?

Elixinol Wellness' management team includes the following people:

Mr. Oliver Horn B.Sc., Global CEO & Exec. Director (Age 49, Pay $395.66k)
Mr. Ron Dufficy BEC, FCPA, Global Chief Financial Officer
Glen Zurcher, Account Director of Investor Relations Department
Ms. Teresa Cleary, Gen. Counsel & Company Sec.
Mr. Rob Hasselman, Pres of Americas
Ms. Beata Silber, Global Head of R&D and Innovation
Ms. Kim Bradley-Ware, Joint Company Sec.

Who are some of Elixinol Wellness' key competitors?

Some companies that are related to Elixinol Wellness include (CSI) (CSI), 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), AFT Pharmaceuticals (AFP), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Ascend Wellness (AWWH), Australian Primary Hemp (APH) and Ayr Wellness (AYRWF).
View all of EXL's competitors.

What is Elixinol Wellness' stock symbol?

Elixinol Wellness trades on the ASX under the ticker symbol "EXL."

How much money does Elixinol Wellness make?

Elixinol Wellness has a market capitalization of $0.00 and generates $15.01 million in revenue each year.

What is Elixinol Wellness' official website?

The official website for Elixinol Wellness is www.elixinolglobal.com.

How can I contact Elixinol Wellness?

The company can be reached via phone at 61 2 4044 4585.

This page was last updated on 7/30/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.